Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Techno Medica Co., Ltd. ( (JP:6678) ) has issued an announcement.
Techno Medica Co., Ltd. reported its non-consolidated financial results for the nine months ended December 31, 2024, showing a slight increase in net sales but significant declines in operating and ordinary profits compared to the previous year. Despite the challenging financial performance, the company maintains a strong equity-to-asset ratio, reflecting financial stability, and plans to maintain its annual cash dividend forecast, indicating a commitment to shareholder returns.
More about Techno Medica Co., Ltd.
Techno Medica Co., Ltd. operates in the healthcare technology industry, focusing on the development and manufacturing of medical devices and equipment. The company is listed on the Tokyo Stock Exchange and targets advancements in medical solutions.
YTD Price Performance: -4.41%
Average Trading Volume: 4,473
Technical Sentiment Consensus Rating: Hold
Current Market Cap: Yen14.93B
Learn more about 6678 stock on TipRanks’ Stock Analysis page.